Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Apligraf Versus Standard Therapy in the Treatment of Diabetic Foot Ulcers

This study has been terminated.
(Interruption of business relations between Study Sponsor and Device Manufacturer)
Sponsor:
Information provided by:
Organogenesis
ClinicalTrials.gov Identifier:
NCT00512538
First received: August 3, 2007
Last updated: NA
Last verified: August 2007
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2002
  Estimated Primary Completion Date: No date given